skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Update on the treatment of disseminated fusariosis: Focus on voriconazole

(2779) Views  (517) Full article downloads

Authors: Marta Stanzani, Fabio Tumietto, Nicola Vianelli, Michele Baccarani

Published Date January 2007 Volume 2007:3(6) Pages 1165 - 1173
DOI: http://dx.doi.org/10.2147/TCRM.S

Marta Stanzani1, Fabio Tumietto2, Nicola Vianelli1, Michele Baccarani1

1Institute of Haematology and Clinical Oncology “Ariosto e Lorenzo Seràgnoli”, S. Orsola-Malpighi Hospital, University of Bologna, Italy; 2Division of Infectious Diseases, S. Orsola-Malpighi Hospital, University of Bologna, Italy

Abstract: Invasive fungal infections are a major cause of morbidity and mortality in immunocompromised patients, such as subjects with hematological malignancies and patients who underwent to hematopoietic stem cell transplantation (HSCT) or solid organ transplantation (SOT). Fusarium spp. cause a broad spectrum of infections in humans. Immunologically competent hosts show mainly localized skin infections, whereas disseminated fusariosis occurs almost exclusively in immunocompromised patients. Fusarium spp. are resistant to many antifungal agents with equivocal in vitro and in vivo susceptibility to amphotericin B. Voriconazole (VRC) is a triazole shown to be safe, well tolerated, and in vitro efficacious against Fusarium spp. Although clinical experience is limited, many case reports have shown the efficacy of VRC in the treatment of fusariosis.

Keywords: fusariosis, voriconazole, immunocompromised patient, cancer, fungal infections, aspergillus








Readers of this article also read:

Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: Comparison with high cardiovascular risk population
A case of polypoidal choroidal vasculopathy. Periphery is equally important for such patients
Information technology in pharmacovigilance: Benefits, challenges, and future directions from industry perspectives
Medical treatment of Cushing's disease: Overview and recent findings
New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents
Refinement of rigid-body protein–protein docking using backbone and side-chain minimization with a coarse-grained model
Activities of key glycolytic enzymes in the plasma of Saudi autistic patients
The role of rasagiline in the treatment of Parkinson’s disease
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Wearing facemasks when performing lumbar punctures: a snapshot of current practice amongst trainee doctors